FDA Adverse Event Injury Summary report: N

INFUSE BONE GRAFT

MDR report key: 3193043 · Received June 27, 2013

Report

Report Number
1030489-2013-02586
Event Type
Injury
Date Received
June 27, 2013
Report Date
October 10, 2016
Manufacturer
MEDTRONIC SOFAMOR DANEK USA, INC
Product Code
NEK
PMA / PMN Number
P000058
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
MN, US
Reporter Occupation
ATTORNEY

Narratives

Additional Manufacturer Narrative · 1

(B)(4). NEITHER THE DEVICE NOR FILMS OF APPLICABLE IMAGING STUDIES WERE RETURNED TO THE MANUFACTURER FOR EVALUATION. THEREFORE, WE ARE UNABLE TO DETERMINE THE DEFINITIVE CAUSE OF THE REPORTED EVENT. PRODUCTS FROM MULTIPLE MANUFACTURERS WERE IMPLANTED DURING THE PROCEDURE. ALTHOUGH IT IS UNKNOWN IF ANY OF THE DEVICES CONTRIBUTED TO THE REPORTED EVENT, WE ARE FILING THIS MDR FOR NOTIFICATION PURPOSES.

Additional Manufacturer Narrative · 1

IF INFORMATION IS PROVIDED IN THE FUTURE, A SUPPLEMENTAL REPORT WILL BE ISSUED.

Description of Event or Problem · 1

IT WAS REPORTED THAT THE PATIENT UNDERWENT AN L4-L5 FUSION USING RHBMP-2/ACS. SUBSEQUENTLY, THE PATIENT WAS DIAGNOSED WITH INJURIES INCLUDING BUT NOT LIMITED TO, ECTOPIC BONE GROWTH, AN INFLAMMATORY REACTION TO RHBMP-2/ACS, CHRONIC PAIN, AND ADDITIONAL SURGERIES. THE PATIENT HAS REQUIRED EXTENSIVE MEDICAL TREATMENT. REPORTEDLY, THE PATIENT HAS NEVER RECOVERED FROM HIS SURGERY INVOLVING RHBMP-2/ACS, AND HE CONTINUES TO HAVE DAILY SEVERE DISABLING PAIN THAT PREVENTS HIM FROM PERFORMING MANY BASIC ACTIVITIES OF DAILY LIVING.

Description of Event or Problem · 1

IT WAS REPORTED THAT ON (B)(6) 2006, THE PATIENT PRESENTED WITH PRE-OP DIAGNOSIS: L4-5 INSTABILITY AND UNDERWENT FOLLOWING PROCEDURES: L4-5 POSTERIOR LUMBAR INTERBODY FUSION. L4 LAMINECTOMY WITH BILATERAL FACETECTOMIES AND FORAMINOTOMIES FOR DECOMPRESSION. L4-5 POSTERIOR SEGMENTAL INSTRUMENTATION. L4-5 POSTEROLATERAL BILATERAL MORCELIZED AUTOGRAFT FUSION. INTRAOPERATIVE INTERPRETATION OF FLUOROSCOPIC IMAGES. PER OP-NOTES: ¿"ONCE THE DISCECTOMY WAS COMPLETED ON EACH SIDE, THEN, WORKING ON THE LEFT AND THE RIGHT RHBMP-2 PREPARATION WAS PLACED ANTERIORLY WITHIN THE DISC SPACE ALONG WITH MORCELIZED AUTOGRAFT CHIPS. TEN MILLIMETRES (10 MM) HEIGHT CAGES WERE THEN PACKED WITH RHBMP-2 AND AUTOGRAFT CHIPS AND THESE WERE THEN PLACED INTO THE INTERBODY SPACE, CONTROLLING THEIR ADVANCEMENT WITH LATERAL FLUOROSCOPY. POSTERIOR TO THE CAGES THEN, MORE MORCELIZED AUTOGRAFT CHIPS WERE PLACED UP TO THE LEVEL OF THE POSTERIOR ASPECT OF THE VERTEBRAL BODY AND THEY WERE PACKED IN. THE PROCEDURE WAS COMPLETED WITHOUT ANY ISSUES. NO PATIENT COMPLICATIONS WERE REPORTED AS A RESULT OF THIS EVENT."

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
294690 INFUSE BONE GRAFT FILLER, RECOMBINANT HUMAN BONE MORPHOGENETIC PROTEIN, COLLAGEN SCAFFOLD WITH MET NEK MEDTRONIC SOFAMOR DANEK USA, INC NA UNK

Patients

Seq Age Sex Outcome Treatment
1 00061 YR Required Intervention